Share
Copied
The study made by Chinese scientists on a new vaccine manufacturing strategy is published in the latest edition of Nature Biomedical Engineering. /Nature
Chinese scientists have developed a new vaccine manufacturing strategy which involves wrapping live virus in a protective hydrogel to activate body's immune response quickly, safely and effectively.
The threat of new viral outbreaks has heightened the need for ready-to-use vaccines that are safe and effective. However, the whole-virus vaccine strategies, such as inactivation, tend to have reduced immunity, safety concerns and time-consuming manufacturing processes, hampering extensive application.
The researchers from Zhejiang University and Beijing Institute of Biotechnology demonstrated an experimental vaccine consisting of live wild-type Zika virus, a mosquito-borne single-stranded RNA virus.
They trapped the virus in a hydrogel with Chitosan scaffolds that can prevent the viral particles from escaping via electrostatic interactions but allow the passage of immune cells.
The vaccine, injected under the skin in mice, is shown to enable the activation of innate immune responses, leading to effective humoral and cellular immunity and protecting the rodent against lethal Zika infection, according to the study published in the latest edition of Nature Biomedical Engineering.
This proof-of-concept study suggested that virulent virus strains can be directly transformed into vaccines by engineering virus-entrapped microenvironments.
It represented a promising strategy for protection against emerging infectious diseases, the researchers said.
Search Trends
SITEMAP
Copyright © 2023 CGTN. 京ICP备16065310号
Disinformation report hotline: 010-85061466
SITEMAP
Copyright © 2023 CGTN. 京ICP备16065310号
Disinformation report hotline: 010-85061466